Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-28 Sale | 2022-03-02 3:20 pm | Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer | 12,452 | $10.24 | $127,477 | 1,638,888 (Indirect Direct) | View |
| 2022-02-17 Sale | 2022-02-22 4:15 pm | Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer | 18,167 | $12.12 | $220,246 | 1,603,340 (Indirect Direct) | View |
| 2022-02-07 Sale | 2022-02-09 5:22 pm | Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer | 13,471 | $9.862 | $132,851 | 1,621,507 (Indirect Direct) | View |
| 2021-03-18 Sale | 2021-03-23 07:50 am | Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO | 4,000 | $12.39 | $49,553 | 1,634,978 (Indirect Direct) | View |
| 2021-02-18 Sale | 2021-02-22 8:10 pm | Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO | 18,990 | $14.83 | $281,644 | 1,351,578 (Indirect Direct) | View |
| 2021-02-11 Sale | 2021-02-17 6:45 pm | Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO | 13,243 | $15.52 | $205,518 | 1,457,768 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-13 Option Award | 2025-06-17 5:54 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 5:27 pm | N/A 2034-06-19 | Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2022-11-14 Option Award | 2022-11-16 7:28 pm | N/A 2032-11-13 | Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director | 35,235 | $0 | 35,235 (Direct) | View |
| 2022-03-29 Option Award | 2022-03-31 4:17 pm | N/A 2032-03-28 | Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer | 150,000 | $0 | 1,761,888 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 3:20 pm | N/A 2032-02-27 | Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer | 48,000 | $0 | 1,638,888 (Indirect) | View |
| 2021-02-25 Option Award | 2021-03-01 8:09 pm | N/A 2031-02-24 | Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO | 364,200 | $0 | 1,945,978 (Direct) | View |
| 2021-02-15 Exercise | 2021-02-17 6:45 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO | 43,600 | $0 | 1,457,768 (Direct) | View |
| 2021-02-05 Exercise | 2021-02-09 8:30 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO | 28,600 | $0 | 1,426,011 (Direct) | View |